Global Intravenous (IV) Fluid Bags Market Report and Forecast 2024-2032

Global Intravenous (IV) Fluid Bags Market Outlook

The global intravenous (IV) fluid bags market size is expected to grow at a CAGR of 5.10% between 2024 and 2032. The market is being driven by the rising demand for intravenous (IV) fluid bags from healthcare units.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Market

An intravenous (IV) fluid bag refers to a sterile bag which stores fluids, such as medicines, chemicals, or blood, that are intended to be injected in a patient’s body intravenously. These bags ensure timely and efficient delivery of larger volumes of medical fluids while protecting the contents from contamination. Intravenous (IV) fluid bags are usually made up of polyvinyl chloride (PVC). 

• The increasing demand for intravenous (IV) fluid bags for safe and risk-free administration of IV fluids, is driving the global intravenous (IV) fluid bags market. According to typical guidelines of hospitals, intravenous (IV) fluid bags are a must to ensure safety.

• The increasing prevalence of dehydration and acid base imbalance among the adult and geriatric population, is bolstering the demand for IV fluids across the healthcare units, which is in turn providing impetus to the intravenous (IV) fluid bags market.

• The rising healthcare expenditure leading to an escalation in the standards of healthcare infrastructure and growing health awareness, are further infusing the incorporation of intravenous (IV) fluid bags across hospitals and clinics.

• Growing usage of IV fluids for wellness applications is a key trend in the market. With the increasing awareness regarding the benefits of IV fluids, many consumers are opting for IV fluids for immunity, to treat hangovers, and to improve athletic performance, further increasing the demand for the intravenous fluid bags market.

Opportunities and Challenges

The growing prevalence of chronic conditions such as cancer, tuberculosis, and diabetes, among others, is posing as an opportunity for the market by generating a significant demand for IV fluids. The anticipated increase in demand for more convenient options such as the disposable IV fluid bags, which reduce the cross-contamination while saving hospitals or clinic costs, is anticipated to add to the intravenous (IV) fluid bags market growth in the forecast period. Increasing investments by the households towards home care settings are further expanding the market opportunities, owing to the fact that intravenous (IV) fluid bags can be used anywhere without any hassle. 

However, the anticipated increase in the transition towards oral administration of fluids, owing to the changing patient preference towards minimally invasive treatment procedures is anticipated to pose as a challenge in the global intravenous (IV) fluid bags market. 

Market Analysis

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on fluid type, the market is segmented into normal saline, dextrose, ringer’s lactate, and vitamins, among others. On the basis of application, the market is classified into clinical and wellness, with wellness applications further divided based on wellness type into immunity, hangover treatment, and athletic performance improvement, among others. By end-user, the market is segmented into hospitals, hydration centres/clinics, and home care settings, among others. The regional markets for intravenous (IV) fluid bags are divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.  

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global intravenous (IV) fluid bags market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.

• Baxter International, Inc.

• B. Braun Medical Inc.

• Fresenius Kabi AG

• Becton, Dickinson and Company

• ICU Medical, Inc.

• Others

Market Share by Fluid Type

The normal saline segment, based on fluid type, accounts for a healthy share of the intravenous (IV) fluid bags market. Normal saline is a type of fluid which is used to treat conditions such as dehydration, metabolic alkalosis, and hypovolemia, among others. Hence, the increasing hospitalisation rates, induced by the sedentary lifestyles led by a growing number of people, is propelling the demand for normal saline which is in turn is fuelling the IV fluid bags market. Meanwhile, dextrose is likely to witness a heightened demand due to the increasing prevalence of low blood sugar. 

Market Share by Region

Regionally, North America accounts for a significant share in the market due to the well-established healthcare infrastructure in countries in the region as well as steady supply of IV fluid bags. The growing popularity of intravenous vitamin therapy to treat chronic conditions such as asthma attacks, migraines, and fibromyalgia, among others is further supporting the market growth in the region. Easy accessibility and early adoption of new types of IV bags is likely to bolster market growth over the coming years. The Asia Pacific is also expected to offer lucrative opportunities to the intravenous (IV) fluid bags market owing to the rapid urbanisation and robust growth of local clinics and hospitals. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Baxter International, Inc. is a leading healthcare company which provides high grade products and services to cater to the healthcare demands across the world. The company innovates in kidney care, scientific exchange, and various types of therapies. Baxter International, Inc. was founded in the year 1931 and is currently headquartered in Illinois, United States. 

B. Braun Medical Inc. is a leading producer, manufacturer, marketer, and innovator of medical products. The company providers general purpose IV solutions, dextrose injections, products related to fluid therapy and injectable drugs, and fluid bags which are utilised across various healthcare units. B. Braun Medical Inc. was established in 1839 and is currently headquartered in Pennsylvania, United States. 

Fresenius Kabi AG is a renowned pharmaceutical company which produces lifesaving medicines and technologies aimed towards carrying out infusions, transfusions, and clinical nutrition. The product portfolio of Fresenius Kabi AG includes innovative IV solutions such as Freeflex and Freeflex+, among others. It was founded in 1999 and is headquartered in Bad Homburg, Germany. 

Other market players include Becton, Dickinson and Company, and ICU Medical, Inc., among others.

Key Highlights of the Report